Company: HCWB
Filing Date: 2025-05-09
Form Type: S-1
Source: 0001193125-25-116745
Chunk: 132

Company: HCW Biologics Inc.
Filing Date: 2025-05-09
Form: S-1
Chunk 132
---
 securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus 
 filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in         
 the effective registration statement; and                                                                                                                                                                                                               |

| (iii) | to include any material information with respect to the plan of distribution not previously disclosed in the                                                                                                                                   
 registration statement or any material change to such information in the registration statement; provided, however, that paragraphs (i), (ii) and (iii) do not apply if the registration statement is on Form S-1 and the information required 
 to be included in a post- effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the registrant pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 that are  
 incorporated by reference in the registration statement, or is contained in a form of prospectus filed pursuant to Rule 424(b) that is part of the registration statement.                                                                     |

II-6

| (2) | that, for the purpose of determining any liability under the Securities Act, each such post-effective amendment                                                                                               
 shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof; |

| (3) | to remove from registration by means of a post-effective amendment any of the securities being registered which 
 remain unsold at the termination of the offering.                                                               |

| (4) | that, for the purpose of determining liability under the Securities Act to any purchaser: |

| (i) | If the registrant is relying on Rule 430B: |

| (A) | Each prospectus filed pursuant to Rule 424(b) as part of a registration statement relating to an offering,                                                                                                                                       
 other than registration statements relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness. |

Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made